Applying Genomic Medicine to Critically Ill Children, Science and Fiction

Affiliations

Editorial

Ricardo G Branco et al. Pediatr Crit Care Med. 2024.

. 2024 Aug 1;25(8):761-764.

doi: 10.1097/PCC.0000000000003548. Epub 2024 Aug 5.

¹ Both authors: Pediatric Intensive Care Unit, Division of Critical Care, Sidra Medicine, Doha, Qatar.

No abstract available

Conflict of interest statement

The authors have disclosed that they do not have any potential conflicts of interest.

1. Collins FS, McKusick VA: Implications of the Human Genome Project for medical science. JAMA. 2001; 285:540–544
1. Krantz ID, Medne L, Weatherly JM, et al.; NICUSeq Study Group: Effect of whole-genome sequencing on the clinical management of acutely ill infants with suspected genetic disease: A randomized clinical trial [published correction appears in JAMA Pediatr . 2021 December 1;175(12):1295]. JAMA Pediatr. 2021; 175:1218–1226
1. Rodriguez KM, Vaught J, Salz L, et al.: Rapid Whole-Genome Sequencing and Clinical Management in the PICU: A Multi-Center Cohort, 2016–2023. Pediatr Crit Care Med. 2024; 25:699–709
1. Wu ET, Hwu WL, Chien YH, et al.: Critical trio exome benefits in-time decision-making for pediatric patients with severe illnesses. Pediatr Crit Care Med. 2019; 20:1021–1026
1. Lunke S, Eggers S, Wilson M, et al.; Australian Genomics Health Alliance Acute Care Flagship: Feasibility of ultra-rapid exome sequencing in critically ill infants and children with suspected monogenic conditions in the Australian public health care system. JAMA. 2020; 323:2503–2511